Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

Find out more

Home › Resources › Videos and webinars › Moving Compounds to IND Using Predictive Retina Models

Moving Compounds to IND Using Predictive Retina Models

During this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.

Date: Wednesday 19th June 2024

Speakers:

Dr Lauren Black – Distinguished Scientist/Consultant – Charles River Laboratories
Dr Roxana Redis – Associate Science Director – Charles River Laboratories
Dr Valeria Chichagova – Director of Technology – Newcells Biotech

Published

June 19, 2024

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View Today

Please enter the required details to view the webinar. You are not automatically signing up for receiving marketing emails.

Book a Call